Search for: "Janssen Pharmaceuticals Inc." Results 121 - 140 of 195
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Nov 2012, 6:14 am by Gene Quinn
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
26 Dec 2011, 1:02 am by Victoria VanBuren
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
9 May 2017, 4:42 am
Searle LLC (2) Janssen Sciences Ireland UC [2017] EWHC 987 (Pat). [read post]
7 Feb 2017, 11:58 am by Clay Hodges
Invokana Janssen Pharmaceuticals paid $20.9 million in payments to doctors promoting the diabetes drug Invokana. [read post]
1 Sep 2017, 5:00 am by melissalafreniere
It is made by Janssen Pharmaceuticals Inc. and Bayer Healthcare Pharmaceuticals Inc., both defendants in this Xarelto wrongful death lawsuit. [read post]
24 Feb 2016, 5:14 am
Janssen Pharmaceuticals, Inc., 2016 WL 633673 (E.D. [read post]
18 Apr 2011, 12:40 pm by Tom Lamb
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called the "package insert" or "label") for its Ortho Evra (norelgestromin/ ethinyl estradiol) transdermal system to give a stronger warning about blood clot related side effects like pulmonary embolism (PE) and deep… [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
29 Jun 2018, 5:00 am by Laura Pennington
Across state and federal courts, Bayer Health Care Pharmaceuticals Inc. and their Johnson & Johnson subsidiary, Janssen Pharmaceuticals, have faced five different trials already regarding the Xarelto bleeding risk. [read post]
7 Mar 2016, 1:55 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive… [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
28 Jun 2010, 3:50 am by Steve McConnell
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2181 (Phila. [read post]
19 Jun 2017, 11:15 am by Edward Smith
Jenssen Pharmaceuticals, Invokana’s manufacturer, also warns patients that this drug can increase their chances of suffering bone fractures and various allergic reactions. [read post]
31 Aug 2019, 8:25 am by Simmons Hanly Conroy
Johnson & Johnson is named as a defendant in the MDL, along with 21 other pharmaceutical companies, including Janssen, Allergan, Teva Pharmaceuticals and Purdue. [read post]